ValiRx plc (LON:VAL – Get Free Report) was down 10% during trading on Wednesday. The company traded as low as GBX 0.15 and last traded at GBX 0.15. 36,266,617 shares traded hands during mid-day trading, an increase of 172% from the average session volume of 13,324,604 shares. The stock had previously closed at GBX 0.17.
ValiRx Price Performance
The firm has a market capitalization of £1.98 million, a price-to-earnings ratio of -0.37 and a beta of 0.59. The business has a 50 day moving average of GBX 0.14 and a 200 day moving average of GBX 0.21.
ValiRx (LON:VAL – Get Free Report) last posted its quarterly earnings results on Tuesday, September 15th. The company reported GBX (0.09) earnings per share for the quarter. ValiRx had a negative return on equity of 71.49% and a negative net margin of 6,548.06%. On average, sell-side analysts forecast that ValiRx plc will post -1.74 EPS for the current fiscal year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Recommended Stories
- Five stocks we like better than ValiRx
- Heavy Lifting: Can USA Rare Earth Turn Its First Sales Into Big Profits?
- These 3 Stocks Have Bought Back Billions, But Which Offers the Best Value?
- Golden Dome’s $185 Billion Question: Who Actually Gets Paid?
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
